General Information
Version
6.4
Revision date
2021-10-28
Product name
Normorphine
CAS No.
466-97-7
REACH No
A
Emergency telephone
+(45)-6991 8573, +(45)-8212 1212
Icons in SDS
Company Information
company name
Merck Life Science ApS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H336
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Warning Warning
Hazard statements
H302 Harmful if swallowed. H336 May cause drowsiness or dizziness. none
Precautionary statements
P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P301 + P312 IF SWALLOWED: Call a POISON CENTER/ doctor if you feel unwell. P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. Supplemental Hazard none Statements Reduced Labeling (<= 125 ml) none
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336 For the full text of the H-Statements mentioned in this Section, see Section 16.
